Nova Eye Medical Limited
ELXMF
Price:
$0.1
Market Cap:
$39.87M
Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma. The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Asia Pacific, and internationally. The company was formerly known as Ellex Medical Lasers Limited and changed its name t...[Read more]
Industry
Medical - Devices
IPO Date
2010-01-20
Stock Exchange
OTC
Ticker
ELXMF
PE Ratio
[-2.00]
ROE
[-49.85%]
Current Ratio
[2.39]
Dividend Yield
[0%]
Enterprise Value
[37.84M]
Dividend History
The ROE as of December 2025 (TTM) for Nova Eye Medical Limited (ELXMF) is -49.85%
According to Nova Eye Medical Limited’s latest financial reports and current stock price. The company's current ROE is -49.85%. This represents a change of 102.97% compared to the average of -24.56% of the last 4 quarters.
Nova Eye Medical Limited (ELXMF) Historical ROE (quarterly & annually)
How has ELXMF ROE performed in the past?
The mean historical ROE of Nova Eye Medical Limited over the last ten years is -21.08%. The current -49.85% ROE has changed 136.54% with respect to the historical average. Over the past ten years (40 quarters), ELXMF's ROE was at its highest in in the June 2010 quarter at 5.78%. The ROE was at its lowest in in the June 2009 quarter at -37.90%.
Average
-21.08%
Median
-11.00%
Minimum
-65.94%
Maximum
6.27%
Nova Eye Medical Limited (ELXMF) ROE by Quarter and Year
Discovering the peaks and valleys of Nova Eye Medical Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 341.17%
Maximum Annual ROE = 6.27%
Minimum Annual Increase = -125.03%
Minimum Annual ROE = -65.94%
| Year | ROE | Change |
|---|---|---|
| 2025 | -47.76% | 15.90% |
| 2024 | -41.21% | -37.51% |
| 2023 | -65.94% | 167.41% |
| 2022 | -24.66% | 100.04% |
| 2021 | -12.33% | 77.37% |
| 2020 | -6.95% | -28.22% |
| 2019 | -9.68% | 39.76% |
| 2018 | -6.93% | 341.17% |
| 2017 | -1.57% | -125.03% |
| 2016 | 6.27% | 48.58% |
Nova Eye Medical Limited (ELXMF) Average ROE
How has ELXMF ROE performed in the past?
The current ROE of Nova Eye Medical Limited (ELXMF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-51.64%
5-year avg
-38.38%
10-year avg
-21.08%
Nova Eye Medical Limited (ELXMF) ROE vs. Peers
How is ELXMF’s ROE compared to its peers?
Nova Eye Medical Limited’s ROE is greater than PetVivo Holdings, Inc. (-332.05%), greater than ImpediMed Limited (-80.35%), greater than Alternate Health Corp. (-279.24%), greater than Next Science Limited (-491.26%), greater than Ecofibre Limited (-51.27%), greater than Novacyt S.A. (-61.81%), greater than Positron Corporation (-531.64%), less than WOWI, Inc. (157.95%), less than Provectus Biopharmaceuticals, Inc. (116.02%), greater than Perimeter Medical Imaging AI, Inc. (-190.26%),
| Company | ROE | Market cap |
|---|---|---|
| -332.05% | $26.74M | |
| -80.35% | $24.04M | |
| -279.24% | $7.79K | |
| -491.26% | $24.00M | |
| -51.27% | $378.87K | |
| -61.81% | $36.02M | |
| -531.64% | $19.37M | |
| 157.95% | $6.65K | |
| 116.02% | $30.26M | |
| -190.26% | $16.23M |
Build a custom stock screener for Nova Eye Medical Limited (ELXMF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nova Eye Medical Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Nova Eye Medical Limited (ELXMF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Nova Eye Medical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Nova Eye Medical Limited's ROE?
How is the ROE calculated for Nova Eye Medical Limited (ELXMF)?
What is the highest ROE for Nova Eye Medical Limited (ELXMF)?
What is the 3-year average ROE for Nova Eye Medical Limited (ELXMF)?
What is the 5-year average ROE for Nova Eye Medical Limited (ELXMF)?
How does the current ROE for Nova Eye Medical Limited (ELXMF) compare to its historical average?